If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarks & Spencer Regulatory News (MKS)

Share Price Information for Marks & Spencer (MKS)

Share Price is delayed by 15 minutes
Get Live Data
375.30    -7.70 (-2.01%)
Bid:
375.00
Ask:
375.40
Spread: 0.40 (0.107%)
Market Cap: £7.71b
MKS Live PriceLast checked at - London Stock Exchange

Intraday Marks & Spencer Share Chart

Replacement - Director/PDMR Shareholding

28 Jul 2015 09:43

RNS Number : 2764U
Marks & Spencer Group PLC
28 July 2015
 



 

28 July 2015

 

This amendment has been made to the Director/PDMR Shareholding announcement released on 24 July 2015 at 16:31 under RNS No 0798U.

 

The announcement below has been amended to correct the total shareholding for Helen Weir under item 2.

 

All other details remain unchanged.

 

The full amended text is shown below.

 

 

Marks and Spencer Group Plc (the 'Company') Notification of Transactions Of Directors/Persons Discharging Managerial Responsibility

 

1. Performance Share PlanIt was confirmed today that the following awards under the Marks and Spencer Group Performance Share Plan were made to PDMRs of the Company:

Directors

Allocation of Performance Shares

(See Note Below)

Marc Bolland

456,974

Helen Weir

276,527

Patrick Bousquet-Chavanne 1

255,905

Steve Rowe

260,826

Laura Wade-Gery

266,451

 

Note: This award was granted as a nil cost option, where a participant will normally be entitled to exercise their award and receive free shares between the third and tenth anniversary of grant, subject to the extent to which performance conditions have been satisfied and their continuing employment 1. The vesting of the award will depend on the Company's Earnings Per Share (EPS), Return On Capital Employed (ROCE) and Revenue performance over a fixed three-year performance period starting on the first day of the financial year in which the award was granted. The value of dividends accrued, in the form of dividend equivalents, will be paid at the end of period (third anniversary) based on the number of vested shares. No consideration was paid for the grant of the award. No price is payable on the exercise of the award. For the purposes of this award, the grant was made at a share price of £5.334.

1 Patrick Bousquet-Chavanne's award is structured as conditional shares which vest on the third anniversary of grant.

 

2. Shareholdings of PDMRs

Directors

Total Holding of Ordinary Shares

Total Percentage Holding in the Company

Marc Bolland

683,929

De minimis

Helen Weir

2,000

De minimis

Patrick Bousquet-Chavanne

2,000

De minimis

Steve Rowe

188,535

De minimis

Laura Wade-Gery

172,955

De minimis

The above holdings are at 24 July 2015, being the date of this announcement, and include holdings for Connected Persons.

The above information has been disclosed under DTR 3.1.4.

 

For Queries please contact:

Corporate PR +44 (0)20 8718 1919

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEAPXPALESEEF
Date   Source Headline
1st Oct 20259:00 amRNSTotal Voting Rights
30th Sep 202511:36 amRNSDirector/PDMR Shareholding
1st Sep 20259:00 amRNSTotal Voting Rights
28th Aug 20252:23 pmRNSDirector/PDMR Shareholding
20th Aug 20259:30 amRNSDirectorate Change
1st Aug 20259:00 amRNSTotal Voting Rights
29th Jul 202512:43 pmRNSDirector/PDMR Shareholding
18th Jul 20252:57 pmRNSDirector/PDMR Shareholding
9th Jul 20259:59 amRNSDirector/PDMR Shareholding
7th Jul 20251:43 pmRNSDirector/PDMR Shareholding
1st Jul 20251:47 pmRNSResult of AGM
1st Jul 20259:00 amRNSBlock listing Interim Review
1st Jul 20259:00 amRNSTotal Voting Rights
30th Jun 20251:23 pmRNSDirector/PDMR Shareholding
23rd Jun 20252:38 pmRNSDirector/PDMR Shareholding
6th Jun 20252:07 pmRNSDirector/PDMR Shareholding
2nd Jun 202510:00 amRNSAnnual Financial Report
2nd Jun 20259:00 amRNSTotal Voting Rights
28th May 20254:53 pmRNSDirector/PDMR Shareholding
21st May 20257:00 amRNSFinal Results
13th May 20258:30 amRNSCyber Incident - Further Update
1st May 20259:00 amRNSTotal Voting Rights
29th Apr 202512:55 pmRNSDirector/PDMR Shareholding
25th Apr 20251:43 pmRNSCyber Incident - Further Update
22nd Apr 20252:14 pmRNSCyber Incident Update
1st Apr 20259:00 amRNSTotal Voting Rights
28th Mar 202512:42 pmRNSDirector/PDMR Shareholding
25th Mar 202512:07 pmRNSDirector/PDMR Shareholding
3rd Mar 20259:00 amRNSTotal Voting Rights
28th Feb 202511:20 amRNSDirector/PDMR Shareholding
3rd Feb 20259:00 amRNSTotal Voting Rights
28th Jan 20251:51 pmRNSDirector/PDMR Shareholding
13th Jan 20254:43 pmRNSDirector/PDMR Shareholding
9th Jan 20257:00 amRNSChristmas Trading Results
2nd Jan 20259:00 amRNSTotal Voting Rights
2nd Jan 20259:00 amRNSBlock listing Interim Review
30th Dec 202411:04 amRNSDirector/PDMR Shareholding
6th Dec 202411:09 amRNSDirector/PDMR Shareholding
2nd Dec 20249:00 amRNSTotal Voting Rights
28th Nov 202410:58 amRNSDirector/PDMR Shareholding
26th Nov 20243:43 pmRNSHolding(s) in Company
12th Nov 20249:08 amRNSInvestor Presentation
6th Nov 20247:00 amRNSHalf-year Report
1st Nov 20249:00 amRNSTotal Voting Rights
29th Oct 20243:32 pmRNSDirector/PDMR Shareholding
1st Oct 20249:00 amRNSTotal Voting Rights
30th Sep 202412:35 pmRNSDirector/PDMR Shareholding
26th Sep 202410:05 amRNSDirectorate Change
18th Sep 202411:53 amRNSDirector/PDMR Shareholding
2nd Sep 20249:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.